MK-5172
MK-5172 is a novel P2-P4 quinoxaline macrocyclic HCV NS3/4a protease inhibitor currently in clinical development.
Product Specifications
CAS Number
1206524-85-7
Purity
>98%
Smiles
O1C (N ([H]) [C@] ([H]) (C (N2C ([H]) ([H]) C ([H]) (C ([H]) ([H]) C2 ([H]) C (=O) O[H]) OC2C (C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) [C@]3 ([H]) C ([H]) ([H]) C13[H]) =NC1C ([H]) =C ([H]) C (=C ([H]) C=1N=2) OC ([H]) ([H]) [H]) =O) C (C ([H]) ([H]) [H]) (C ([H]) ([H]) [H]) C ([H]) ([H]) [H]) =O
Molecular Formula
C29H38N4O7
Molecular Weight
554.6346
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
492298 100 µL
SMARCD2 (SWI/SNF-related Matrix-associated Actin-dependent Regulator of Chromatin Subfamily D Member 2)
Sign In for Pricing
View Details